June 2nd is coming..a new rev stream for LBWR??
(USIS...See PR Below)
Also, for the record, I have heard people talk about how this company is a scam and is being promoted by certain people.
I personally do not think it is a scam, but I suppose it could be..to date the company has done everything they said they would so I will assume it is legit unless the COMPANY gives me reason to think otherwise..not MB posters....As most know, you should never act on advice from MB posters..always do your own dd....
I myself did my own dd on lbwr and liked what I saw. My buys at far lower prices are looking quite nice and imo this has potential to run in to the dollars...but as always, nobody should listen to any opinions other then their own and noone should act on anybodies advice other then their own.....Nobody suckered me in to buying lbwr...nobody pumped or promoted lbwr to me trying to entice me to buy....I, like anybody should do, did my own dd and made my own decision as to buy some lbwr or not. I did buy, more then once and each buy I am quite pleased with the current gains and IMO those gains will be growing.
The deal with USIS looks interesting....we will hopefully uplist to .ob status soon. IMO, I think good things are happening with LBWR, but that is just my opinion. If others do not like lbwr then I would suggest staying away from it......
This could go to $5 imo.
It could also go to zero imo.
Each investor should do their own dd and make their own decisions.
Nobody suckered or enticed me to buy and nobody should allow anybody to sucker or entice them to buy or sell any security. It's your money.....it's your decision to buy or sell.....Anybody acting on the advice of a MB poster is not investing properly IMO and should only have themselves to blame as I do not see MB posters putting guns to peoples heads forcing them to buy or sell anything. If you allow a stranger to get in your wallet, blame yourself for poor decisions.
All in my opinion of course...
<<Labwire Signs Alliance Agreement With USIS
9:00 AM EDT May 15, 2008
HOUSTON, TX -- (MARKET WIRE) -- 05/15/08 -- Labwire, Inc. (PINKSHEETS: LBWR), a leading provider of employee screening solutions, security, and compliance surveillance services, is pleased to report that on April 30, 2008 Labwire signed an Alliance Agreement with USIS, a large national commercial services group. Under the terms of the Alliance Agreement, Labwire will perform drug/alcohol testing services and pre-employment background screening products and services for certain USIS clients: in turn, USIS will offer their products for sale by Labwire to its clients. The agreement is for an initial term of two (2) years and provides for both firms to pay referral fees based on a percent of business delivered. The initial clients referred by USIS will begin transitioning to Labwire on June 2, 2008 and will continue through year's end and will include several large operating units in commercial transportation industries.
"Mr. Morris and the sales team are to be congratulated for securing this substantial relationship agreement," stated Marlin Williford, CFO. "As this agreement is implemented, it should provide good revenue growth for the 3rd and 4th quarters of this year."
Dexter Morris, Labwire Chairman and CEO, offers the following business insight: "We are excited about our technology gaining the acceptance of a company such as USIS. We see this as a first step in expanding our client base through alliances as well as direct sales and acquisition opportunities. Labwire will continue to seek this type of alliance agreement with other major companies offering various services. We believe that these alliance arrangements will allow Labwire to grow more rapidly utilizing the strength and effectiveness of its operating platform to grow its revenue at a faster rate than conventional sales would allow."
USIS is a worldwide provider of background investigations, pre-employment/drug screenings, insurance information services, due diligence and risk management assessment, and security and related professional services to businesses, federal agencies, and institutions. Headquartered in Falls Church, Va., USIS has more than 7,000 employees supporting business operations in all 50 states, U.S. territories, and overseas. For more information, please visit www.usis.com.
Labwire, Inc., headquartered in Houston, TX, provides secure and compliant employee drug screening and background checking services to Fortune 500 corporations via the Labwire(TM) Platform. Labwire(TM) is a proprietary, web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results while eliminating service calls and paper trails. This comprehensive solution to managing employee screening services is the most efficient and cost-effective platform in the industry. For more information see 8-k filings.
Safe Harbor Provisions:
Certain oral statements made by management from time to time and certain statements contained in press releases and periodic reports issued by Labwire, Inc., (the "Company"), as well as those contained herein, that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934 and, because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements, including those in Management's Discussion and Analysis, are statements regarding the intent, belief or current expectations, estimates or projections of the Company, its Directors or its Officers about the Company and the industry in which it operates, and are based on assumptions made by management. Forward-looking statements include without limitation statements regarding: (a) the Company's strategies regarding growth and business expansion, including future acquisitions; (b) the Company's financing plans; (c) trends affecting the Company's financial condition or results of operations; (d) the Company's ability to continue to control costs and to meet its liquidity and other financing needs; (e) the declaration and payment of dividends; and (f) the Company's ability to respond to changes in customer demand and regulations. Although the Company believes that its expectations are based on reasonable assumptions, it can give no assurance that the anticipated results will occur. When issued in this report, the words "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," and similar expressions are generally intended to identify forward-looking statements.
Important factors that could cause the actual results to differ materially from those in the forward-looking statements include, among other items, (i) changes in the regulatory and general economic environment; (ii) conditions in the capital markets, including the interest rate environment and the availability of capital; (iii) changes in the competitive marketplace that could affect the Company's revenue and/or cost and expenses, such as increased competition, lack of qualified marketing, management or other personnel, and increased labor and inventory costs; (iv) changes in technology or customer requirements, which could render the Company's technologies noncompetitive or obsolete; (v) new product introductions, product sales mix and the geographic mix of sales.
The Company disclaims any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this advertisement are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, governmental approval processes, the impact of competitive products or pricing, technological changes, and the effect of economic conditions.
Investor and Public Relations Contact: Marlin R. Williford Jr. email: mwilliford@capnetrisk.com Phone: (832) 487-7803
GB-ND
creede>> |
